Wockhardt gets NDA status for novel antibiotic Zaynich
agency-feeds
N
News18 English•01/12/2025
Wockhardt gets NDA status for novel antibiotic Zaynich
- •Wockhardt's antibiotic Zaynich gets NDA status from US FDA.
- •First Indian NCE to be accepted by US FDA.
- •Zaynich granted fast-track designation by US FDA.
- •Wockhardt shares rise 18.93% to Rs 1,467 on BSE.
✦
Related Articles
Loading more articles...
